![](/img/cover-not-exists.png)
EPS3.3 Plasma levels of the bioactive sphingolipid S1P are reduced in cystic fibrosis patients after lung transplantation depending on CFTR mutation
Halilbasic, E., Fuerst, E., Heiden, D., Japtok, L., Diesner, S.C., Hillebrand, P., Vogelsang, H., Trauner, M., Kulu, A., Jaksch, P., Klepetko, W., Kleuser, B., Kazemi-Shirazi, L., Untersmayr, E.Volume:
16
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(17)30294-1
Date:
June, 2017
File:
PDF, 73 KB
english, 2017